SANDEEP GAONKAR: Open Payments
NPI 1124084967 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,189 in 309 payments from 26 companies in 2025. Trend: 2023 $4,970 · 2024 $5,081 · 2025 $7,189
Food & beverage: $7,119Education: $70
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 33 | $950 |
| ABBVIE INC. | 41 | $932 |
| Neurocrine BioSciences, Inc. | 28 | $817 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $687 |
| Otsuka America Pharmaceutical, Inc. | 27 | $649 |
| Lundbeck LLC | 16 | $369 |
| Teva Pharmaceuticals USA, Inc. | 22 | $342 |
| E.R. Squibb & Sons, L.L.C. | 16 | $333 |
| Axsome Therapeutics, Inc. | 13 | $329 |
| HARMONY BIOSCIENCES LLC | 11 | $328 |
Products named: FANAPT, VRAYLAR, REXULTI, INGREZZA, CAPLYTA, COBENFY, WAKIX, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
